193 related articles for article (PubMed ID: 14988905)
1. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations.
Pedra CA; Pedra SR; Esteves CA; Pontes SC; Braga SL; Arrieta SR; Santana MV; Fontes VF; Masura J
Catheter Cardiovasc Interv; 2004 Mar; 61(3):403-10. PubMed ID: 14988905
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
[TBL] [Abstract][Full Text] [Related]
3. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.
Bass JL; Kalra GS; Arora R; Masura J; Gavora P; Thanopoulos BD; Torres W; Sievert H; Carminati M; Fischer G; Ewert P
Catheter Cardiovasc Interv; 2003 Feb; 58(2):238-45. PubMed ID: 12552550
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous closure of perimembranous ventricular septal defects: initial experience in Portugal.
Ferreira R; Pereira A; Rossi R; Teixeira A; Nunes M; Menezes I; Anjos R; Martins FM
Rev Port Cardiol; 2009 Mar; 28(3):291-301. PubMed ID: 19480312
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.
Fu YC; Bass J; Amin Z; Radtke W; Cheatham JP; Hellenbrand WE; Balzer D; Cao QL; Hijazi ZM
J Am Coll Cardiol; 2006 Jan; 47(2):319-25. PubMed ID: 16412854
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter closure of congenital muscular ventricular septal defect.
Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
[TBL] [Abstract][Full Text] [Related]
7. Complete heart block associated with device closure of perimembranous ventricular septal defects.
Predescu D; Chaturvedi RR; Friedberg MK; Benson LN; Ozawa A; Lee KJ
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1223-8. PubMed ID: 19026807
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
Szkutnik M; Kusa J; Białkowski J
Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous closure of ventricular septal defect by Amplatzer occluder. Immediate and mid-term follow up results].
Zabal C; García Montes JA; Calderón Colmenero J; Patiño Bahena E; Buendía Hernández A; Attie F
Arch Cardiol Mex; 2005; 75(3):327-34. PubMed ID: 16294823
[TBL] [Abstract][Full Text] [Related]
10. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience.
Hijazi ZM; Hakim F; Haweleh AA; Madani A; Tarawna W; Hiari A; Cao QL
Catheter Cardiovasc Interv; 2002 Aug; 56(4):508-15. PubMed ID: 12124963
[TBL] [Abstract][Full Text] [Related]
11. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system.
Fischer G; Apostolopoulou SC; Rammos S; Schneider MB; Bjørnstad PG; Kramer HH
Cardiol Young; 2007 Oct; 17(5):499-504. PubMed ID: 17634162
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
13. Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey.
Celiker A; Ozkutlu S; Karagöz T; Erdoğan I; Ozer S; Aypar E
Turk J Pediatr; 2008; 50(2):106-13. PubMed ID: 18664072
[TBL] [Abstract][Full Text] [Related]
14. Technology Insight: transcatheter closure of ventricular septal defects.
Moodie DS
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of perimembranous ventricular septal defect with immediate follow-up.
Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A; Nutakul T
J Med Assoc Thai; 2003 Oct; 86(10):911-7. PubMed ID: 14650702
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
Holzer R; de Giovanni J; Walsh KP; Tometzki A; Goh T; Hakim F; Zabal C; de Lezo JS; Cao QL; Hijazi ZM
Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
[TBL] [Abstract][Full Text] [Related]
17. Closure of perimembranous ventricular septal defect using transcatheter technique versus surgical repair.
Pawelec-Wojtalik M; Wojtalik M; Mrówczyński W; Surmacz R
Kardiol Pol; 2005 Dec; 63(6):595-602; discussion 603-4. PubMed ID: 16380857
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.
Djer MM; Latiff HA; Alwi M; Samion H; Kandavello G
Heart Lung Circ; 2006 Feb; 15(1):12-7. PubMed ID: 16473785
[TBL] [Abstract][Full Text] [Related]
19. Device fracture and severe tricuspid regurgitation after percutaneous closure of perimembranous ventricular septal defect: a case report.
Mertens L; Meyns B; Gewillig M
Catheter Cardiovasc Interv; 2007 Nov; 70(5):749-53. PubMed ID: 17563097
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
Zhao PJ; Yu ZQ; Gao W; Li F; Fu LJ; Liu TL; Li Y; Zhang YQ; Huang MR; Guo Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
